<https://rdf.molmedb.upol.cz/reference/ref3138> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM489347>,
		<https://rdf.molmedb.upol.cz/interaction/membrane46>;
	<http://purl.org/dc/terms/bibliographicCitation> "Subramanian G, Bowen SJ, Zhu Y, Roush N, Zachary T, Javens C, Williams T, Janssen A, Gonzales A.: Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA). Bioorg Med Chem Lett, Volume 29 (19), 2019"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2019.126624"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method71>;
	<http://purl.org/ontology/bibo/pmid> "31444087"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM489329> .
<https://rdf.molmedb.upol.cz/interaction/int1008240> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3138> .
<https://rdf.molmedb.upol.cz/interaction/int1008270> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3138> .
<https://rdf.molmedb.upol.cz/interaction/int1008239> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3138> .
<https://rdf.molmedb.upol.cz/interaction/int1008269> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3138> .
